Brainstorm Cell Therapeutics In

Q4 2024 13F Holders

Symbol
BCLI
CUSIP
10501E300
Type
Equity
Class
COM
Num filings
32
Total reported value, excl. options
$473 k
Manager Report Date Value ($000) Shares Option Type